RESEARCH
Tracking ctDNA after surgery identifies high-risk patients despite negative MRD statusA longitudinal study of 124 stage II-III patients found that analyzing circulating tumor DNA (ctDNA) trajectories after surgery can identify subgroups at high risk for recurrence or metastasis, even when initial minimal residual disease testing is negative. (J Gastrointest Oncol)